EXAS vs SNPS · rev $2.76B vs P/E 63, rev $7.16B
EXACT Sciences Corporation (EXAS) versus Synopsys Inc (SNPS) — a side-by-side from cached financials, not a winner call.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
Synopsys Inc (SNPS) is a software - infrastructure company listed on US.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
Latest reported SNPS revenue for 2026-07-31 was $7.16B. Net income was $627.9M. Revenue was up 52.9% from 2026-04-30 to 2026-07-31. SNPS currently screens at market cap $85.14B and trailing P/E 63.3.
EXAS currently screens at market cap $20.03B. SNPS currently screens at market cap $85.14B and trailing P/E 63.3.
Not investment advice. Open the EXAS and SNPS stock pages for the full models.
Not investment advice.